Researchers detected the presence of a Streptococcus agalactiae (group B Streptococcus) sequence type (ST) 283.
Galderma targets one of this year’s biggest European IPOs with top-of-the-range share price
Galderma, a skincare company that also has an R&D pipeline, is set to start trading on the SIX Swiss Exchange Friday at a premium price